nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—CYP3A4—bone cancer	0.961	1	CbGaD
Pipotiazine—Clomipramine—GSTP1—bone cancer	0.00119	0.21	CrCbGaD
Pipotiazine—Alimemazine—CYP3A4—bone cancer	0.000792	0.14	CrCbGaD
Pipotiazine—Mequitazine—CYP3A4—bone cancer	0.000681	0.12	CrCbGaD
Pipotiazine—Domperidone—CYP3A4—bone cancer	0.000673	0.119	CrCbGaD
Pipotiazine—Prochlorperazine—CYP3A4—bone cancer	0.000463	0.0819	CrCbGaD
Pipotiazine—Clomipramine—CYP3A4—bone cancer	0.000383	0.0677	CrCbGaD
Pipotiazine—Perphenazine—CYP3A4—bone cancer	0.000331	0.0586	CrCbGaD
Pipotiazine—Quetiapine—CYP3A4—bone cancer	0.000325	0.0574	CrCbGaD
Pipotiazine—Promazine—CYP3A4—bone cancer	0.000299	0.0528	CrCbGaD
Pipotiazine—Chlorpromazine—CYP3A4—bone cancer	0.000263	0.0465	CrCbGaD
Pipotiazine—Imipramine—CYP3A4—bone cancer	0.000261	0.0462	CrCbGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—GRM4—bone cancer	0.000217	0.00659	CbGpPWpGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—RGS1—bone cancer	0.000217	0.00659	CbGpPWpGaD
Pipotiazine—HTR2A—G alpha (q) signalling events—GRM1—bone cancer	0.000196	0.00593	CbGpPWpGaD
Pipotiazine—ALB—Platelet degranulation—SPARC—bone cancer	0.000195	0.00591	CbGpPWpGaD
Pipotiazine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000193	0.00586	CbGpPWpGaD
Pipotiazine—DRD2—G alpha (i) signalling events—GRM4—bone cancer	0.000191	0.00578	CbGpPWpGaD
Pipotiazine—DRD2—G alpha (i) signalling events—RGS1—bone cancer	0.000191	0.00578	CbGpPWpGaD
Pipotiazine—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000186	0.00563	CbGpPWpGaD
Pipotiazine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000183	0.00554	CbGpPWpGaD
Pipotiazine—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00018	0.00547	CbGpPWpGaD
Pipotiazine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000176	0.00534	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000175	0.0053	CbGpPWpGaD
Pipotiazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000168	0.00509	CbGpPWpGaD
Pipotiazine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000166	0.00503	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—GNA11—bone cancer	0.00016	0.00485	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—EZH2—bone cancer	0.000159	0.00483	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—GRM4—bone cancer	0.000153	0.00464	CbGpPWpGaD
Pipotiazine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000148	0.00449	CbGpPWpGaD
Pipotiazine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000142	0.00432	CbGpPWpGaD
Pipotiazine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000141	0.00426	CbGpPWpGaD
Pipotiazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000136	0.00413	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—GRM1—bone cancer	0.000133	0.00402	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—GRM4—bone cancer	0.000132	0.00399	CbGpPWpGaD
Pipotiazine—HTR2A—G alpha (q) signalling events—GNA11—bone cancer	0.000126	0.00382	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—GNA11—bone cancer	0.000121	0.00366	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—EZH2—bone cancer	0.00012	0.00365	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—GRM4—bone cancer	0.000116	0.0035	CbGpPWpGaD
Pipotiazine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000115	0.0035	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—GRM1—bone cancer	0.000114	0.00346	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—GRM4—bone cancer	0.000114	0.00345	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000113	0.00341	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000101	0.00305	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—GRM1—bone cancer	0.0001	0.00304	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—GRM1—bone cancer	9.86e-05	0.00299	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	9.5e-05	0.00288	CbGpPWpGaD
Pipotiazine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	9.37e-05	0.00284	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—SMO—bone cancer	9.35e-05	0.00283	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—CDK4—bone cancer	9e-05	0.00273	CbGpPWpGaD
Pipotiazine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.97e-05	0.00272	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.68e-05	0.00263	CbGpPWpGaD
Pipotiazine—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	8.65e-05	0.00262	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—GRM4—bone cancer	8.65e-05	0.00262	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—RGS1—bone cancer	8.65e-05	0.00262	CbGpPWpGaD
Pipotiazine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	8.1e-05	0.00245	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—SMO—bone cancer	8.04e-05	0.00244	CbGpPWpGaD
Pipotiazine—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	7.92e-05	0.0024	CbGpPWpGaD
Pipotiazine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	7.87e-05	0.00239	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—NDUFA12—bone cancer	7.86e-05	0.00238	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—GRM4—bone cancer	7.86e-05	0.00238	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—RGS1—bone cancer	7.86e-05	0.00238	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.81e-05	0.00237	CbGpPWpGaD
Pipotiazine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	7.76e-05	0.00235	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—GRM1—bone cancer	7.5e-05	0.00227	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—GRM4—bone cancer	7.44e-05	0.00225	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—RGS1—bone cancer	7.44e-05	0.00225	CbGpPWpGaD
Pipotiazine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7.3e-05	0.00221	CbGpPWpGaD
Pipotiazine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.24e-05	0.00219	CbGpPWpGaD
Pipotiazine—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	7.18e-05	0.00217	CbGpPWpGaD
Pipotiazine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.14e-05	0.00216	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—SMO—bone cancer	7.06e-05	0.00214	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	7.04e-05	0.00213	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—SMO—bone cancer	6.95e-05	0.00211	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—GRM1—bone cancer	6.81e-05	0.00206	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—CDK4—bone cancer	6.79e-05	0.00206	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—GRM4—bone cancer	6.76e-05	0.00205	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—RGS1—bone cancer	6.76e-05	0.00205	CbGpPWpGaD
Pipotiazine—CYP2C19—Biological oxidations—GSTP1—bone cancer	6.73e-05	0.00204	CbGpPWpGaD
Pipotiazine—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.72e-05	0.00204	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	6.64e-05	0.00201	CbGpPWpGaD
Pipotiazine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	6.64e-05	0.00201	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—RGS1—bone cancer	6.53e-05	0.00198	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—GRM4—bone cancer	6.53e-05	0.00198	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—NT5C3A—bone cancer	6.51e-05	0.00197	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—GRM1—bone cancer	6.45e-05	0.00195	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—RGS1—bone cancer	6.43e-05	0.00195	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—GRM4—bone cancer	6.43e-05	0.00195	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	6.37e-05	0.00193	CbGpPWpGaD
Pipotiazine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.25e-05	0.00189	CbGpPWpGaD
Pipotiazine—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.19e-05	0.00188	CbGpPWpGaD
Pipotiazine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	6.13e-05	0.00186	CbGpPWpGaD
Pipotiazine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.11e-05	0.00185	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	6.11e-05	0.00185	CbGpPWpGaD
Pipotiazine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	6.05e-05	0.00183	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—RGS1—bone cancer	5.93e-05	0.0018	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—GRM4—bone cancer	5.93e-05	0.0018	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—GRM1—bone cancer	5.86e-05	0.00178	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—GRM4—bone cancer	5.84e-05	0.00177	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—RGS1—bone cancer	5.84e-05	0.00177	CbGpPWpGaD
Pipotiazine—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.8e-05	0.00176	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—JUN—bone cancer	5.8e-05	0.00176	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—GRM1—bone cancer	5.66e-05	0.00172	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—GRM1—bone cancer	5.57e-05	0.00169	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.53e-05	0.00168	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.53e-05	0.00168	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	5.34e-05	0.00162	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	5.28e-05	0.0016	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—NDUFA12—bone cancer	5.26e-05	0.00159	CbGpPWpGaD
Pipotiazine—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.25e-05	0.00159	CbGpPWpGaD
Pipotiazine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	5.17e-05	0.00157	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—GRM1—bone cancer	5.14e-05	0.00156	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—GRM1—bone cancer	5.06e-05	0.00153	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—TP53—bone cancer	4.98e-05	0.00151	CbGpPWpGaD
Pipotiazine—SLC22A1—Neuronal System—BRAF—bone cancer	4.88e-05	0.00148	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—GNA11—bone cancer	4.83e-05	0.00146	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—SMO—bone cancer	4.8e-05	0.00145	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—NDUFA12—bone cancer	4.72e-05	0.00143	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—GRM4—bone cancer	4.64e-05	0.00141	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—RGS1—bone cancer	4.64e-05	0.00141	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—SPARC—bone cancer	4.46e-05	0.00135	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—GNA11—bone cancer	4.39e-05	0.00133	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—IL3—bone cancer	4.38e-05	0.00133	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—JUN—bone cancer	4.38e-05	0.00133	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—NT5C3A—bone cancer	4.36e-05	0.00132	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NDUFA12—bone cancer	4.34e-05	0.00132	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—GNA11—bone cancer	4.16e-05	0.00126	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—SMO—bone cancer	4.13e-05	0.00125	CbGpPWpGaD
Pipotiazine—SLC22A1—Neuronal System—MDM2—bone cancer	4.09e-05	0.00124	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—GNA11—bone cancer	4.08e-05	0.00124	CbGpPWpGaD
Pipotiazine—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.05e-05	0.00123	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—GRM1—bone cancer	4.02e-05	0.00122	CbGpPWpGaD
Pipotiazine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.99e-05	0.00121	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—GRM4—bone cancer	3.99e-05	0.00121	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—RGS1—bone cancer	3.99e-05	0.00121	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—IL3—bone cancer	3.98e-05	0.00121	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—NT5C3A—bone cancer	3.91e-05	0.00118	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—TP53—bone cancer	3.83e-05	0.00116	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—GNA11—bone cancer	3.77e-05	0.00114	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—IL3—bone cancer	3.77e-05	0.00114	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—IL3—bone cancer	3.7e-05	0.00112	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NDUFA12—bone cancer	3.68e-05	0.00111	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—GNA11—bone cancer	3.65e-05	0.00111	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—SMO—bone cancer	3.62e-05	0.0011	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NT5C3A—bone cancer	3.6e-05	0.00109	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—GNA11—bone cancer	3.59e-05	0.00109	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—SMO—bone cancer	3.57e-05	0.00108	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—GRM4—bone cancer	3.5e-05	0.00106	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—RGS1—bone cancer	3.5e-05	0.00106	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—GRM1—bone cancer	3.46e-05	0.00105	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—RGS1—bone cancer	3.45e-05	0.00104	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—GRM4—bone cancer	3.45e-05	0.00104	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—IL3—bone cancer	3.42e-05	0.00104	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—GNA11—bone cancer	3.31e-05	0.001	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—IL3—bone cancer	3.31e-05	0.001	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—GNA11—bone cancer	3.26e-05	0.000988	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—IL3—bone cancer	3.26e-05	0.000987	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.21e-05	0.000972	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NT5C3A—bone cancer	3.05e-05	0.000923	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—GRM1—bone cancer	3.04e-05	0.000921	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—IL3—bone cancer	3e-05	0.00091	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—GRM1—bone cancer	2.99e-05	0.000906	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—IL3—bone cancer	2.96e-05	0.000896	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—TP53—bone cancer	2.89e-05	0.000876	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—ENO2—bone cancer	2.85e-05	0.000864	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.84e-05	0.00086	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—SMO—bone cancer	2.84e-05	0.000859	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—DHFR—bone cancer	2.65e-05	0.000802	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—GNA11—bone cancer	2.59e-05	0.000786	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—GNA11—bone cancer	2.47e-05	0.000749	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SMO—bone cancer	2.44e-05	0.000739	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—PLAU—bone cancer	2.43e-05	0.000735	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—ATF1—bone cancer	2.41e-05	0.000731	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.35e-05	0.000712	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL3—bone cancer	2.35e-05	0.000712	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CYP3A4—bone cancer	2.24e-05	0.000679	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—GNA11—bone cancer	2.23e-05	0.000676	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SMO—bone cancer	2.14e-05	0.000649	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SMO—bone cancer	2.11e-05	0.000638	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—ATF1—bone cancer	2.07e-05	0.000628	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL3—bone cancer	2.02e-05	0.000613	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TGFBR2—bone cancer	2.01e-05	0.000609	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—GNA11—bone cancer	1.96e-05	0.000593	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—GNA11—bone cancer	1.93e-05	0.000584	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—GSTP1—bone cancer	1.92e-05	0.000581	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—ENO2—bone cancer	1.91e-05	0.000578	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IGF1R—bone cancer	1.89e-05	0.000573	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ATF1—bone cancer	1.82e-05	0.000552	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ATF1—bone cancer	1.79e-05	0.000543	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL3—bone cancer	1.78e-05	0.000538	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—DHFR—bone cancer	1.77e-05	0.000536	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL3—bone cancer	1.75e-05	0.000529	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	1.73e-05	0.000524	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ENO2—bone cancer	1.71e-05	0.000519	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GNA11—bone cancer	1.65e-05	0.000501	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IGF1R—bone cancer	1.63e-05	0.000493	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—DHFR—bone cancer	1.59e-05	0.000481	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ENO2—bone cancer	1.58e-05	0.000477	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.52e-05	0.00046	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000454	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.49e-05	0.000453	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.49e-05	0.000452	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GNA11—bone cancer	1.49e-05	0.00045	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—DHFR—bone cancer	1.46e-05	0.000443	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IGF1R—bone cancer	1.43e-05	0.000433	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.41e-05	0.000426	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—KIT—bone cancer	1.37e-05	0.000416	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GNA11—bone cancer	1.37e-05	0.000414	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CYP3A4—bone cancer	1.35e-05	0.000408	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.34e-05	0.000406	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ENO2—bone cancer	1.33e-05	0.000404	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—BRAF—bone cancer	1.29e-05	0.000391	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GSTP1—bone cancer	1.28e-05	0.000389	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—EGFR—bone cancer	1.25e-05	0.000379	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.24e-05	0.000375	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—DHFR—bone cancer	1.24e-05	0.000375	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—KIT—bone cancer	1.18e-05	0.000358	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GNA11—bone cancer	1.16e-05	0.000351	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GSTP1—bone cancer	1.15e-05	0.000349	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.11e-05	0.000336	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MDM2—bone cancer	1.08e-05	0.000327	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.07e-05	0.000326	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GSTP1—bone cancer	1.06e-05	0.000321	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.05e-05	0.000318	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.04e-05	0.000316	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—KIT—bone cancer	1.04e-05	0.000314	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ENO2—bone cancer	1.03e-05	0.000312	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—KIT—bone cancer	1.02e-05	0.000309	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PTGS2—bone cancer	9.93e-06	0.000301	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—TP53—bone cancer	9.75e-06	0.000296	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—BRAF—bone cancer	9.74e-06	0.000295	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—BRAF—bone cancer	9.58e-06	0.00029	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—DHFR—bone cancer	9.55e-06	0.00029	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—EGFR—bone cancer	9.44e-06	0.000286	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—JUN—bone cancer	9.39e-06	0.000285	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MDM2—bone cancer	9.29e-06	0.000282	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—EGFR—bone cancer	9.29e-06	0.000281	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MMP9—bone cancer	9.14e-06	0.000277	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTP1—bone cancer	8.97e-06	0.000272	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GNA11—bone cancer	8.93e-06	0.000271	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MDM2—bone cancer	8.16e-06	0.000247	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—JUN—bone cancer	8.08e-06	0.000245	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MDM2—bone cancer	8.03e-06	0.000243	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MMP9—bone cancer	7.86e-06	0.000238	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—EGFR—bone cancer	7.38e-06	0.000224	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—JUN—bone cancer	7.09e-06	0.000215	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—JUN—bone cancer	6.98e-06	0.000211	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTP1—bone cancer	6.92e-06	0.00021	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MMP9—bone cancer	6.9e-06	0.000209	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MMP9—bone cancer	6.79e-06	0.000206	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTGS2—bone cancer	6.65e-06	0.000201	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—EGFR—bone cancer	6.35e-06	0.000192	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TP53—bone cancer	6.2e-06	0.000188	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTGS2—bone cancer	5.97e-06	0.000181	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—EGFR—bone cancer	5.58e-06	0.000169	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTGS2—bone cancer	5.49e-06	0.000166	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—EGFR—bone cancer	5.49e-06	0.000166	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TP53—bone cancer	5.33e-06	0.000162	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TP53—bone cancer	4.68e-06	0.000142	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTGS2—bone cancer	4.65e-06	0.000141	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TP53—bone cancer	4.61e-06	0.00014	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTGS2—bone cancer	3.59e-06	0.000109	CbGpPWpGaD
